| Literature DB >> 35430619 |
Takayuki Yamaji1, Takahiro Harada1, Yu Hashimoto1, Yukiko Nakano1, Masato Kajikawa2, Kenichi Yoshimura2,3, Kazuaki Chayama4, Chikara Goto5, Yiming Han6, Aya Mizobuchi6, Farina Mohamad Yusoff6, Shinji Kishimoto6, Tatsuya Maruhashi6, Ayumu Nakashima7, Yukihito Higashi8,9.
Abstract
We divided the 466 subjects into two groups based on information on sitting time on a non-working day and evaluated flow-mediated vasodilation (FMD) and nitroglycerine-induced vasodilation (NID). FMD was smaller in subjects with sitting time on a non-working day of ≥6 h/day than in subjects with sitting time on a non-working day of <6 h/day (2.5 ± 2.6% vs. 3.7 ± 2.9%; p < 0.001). NID was smaller in subjects with sitting time at non-working day of ≥ 8 h/day than in subjects with sitting time on a non-working day of < 8 h/day (10.1 ± 5.6% vs. 11.5 ± 5.0%; p = 0.01). After adjustment for confounding factors for vascular function, the odds of having the lowest tertile of FMD was significantly higher in subjects with sitting time on a non-working day of ≥6 h/day than in subjects with sitting time on a non-working day of <6 h/day. The odds of having the lowest tertile of NID was significant higher in subjects with sitting time on a non-working day of ≥ 8 h/day than in subjects with sitting time on a non-working day of < 8 h/day. These findings suggest that prolonged sitting time on a non-working day is associated with blunted FMD and blunted NID.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35430619 PMCID: PMC9012897 DOI: 10.1038/s41598-022-10242-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Clinical characteristics of subjects with sitting time on a non-working day of <6 h/day and subjects with sitting time on a non-working day of ≥6 h/day.
| Variables | Total (n = 446) | < 6 h/day (n = 215) | ≥6 h/day (n = 231) | |
|---|---|---|---|---|
| Age, year | 66 ± 12 | 64 ± 13 | 67 ± 12 | 0.003 |
| Men, n (%) | 265 (59.4) | 129 (60.0) | 136 (58.9) | 0.81 |
| Body mass index, kg/m2 | 24.2 ± 3.7 | 24.0 ± 3.8 | 24.4 ± 3.6 | 0.24 |
| Heart rate, bpm | 68 ± 11 | 66 ± 9 | 70 ± 11 | < 0.001 |
| Systolic blood pressure, mmHg | 128 ± 16 | 130 ± 16 | 126 ± 15 | 0.009 |
| Diastolic blood pressure, mmHg | 77 ± 11 | 79 ± 12 | 75 ± 10 | < 0.001 |
| Total cholesterol, mg/dL | 191 ± 35 | 191 ± 32 | 190 ± 38 | 0.75 |
| Triglycerides, mg/dL | 127 ± 68 | 127 ± 68 | 126 ± 67 | 0.88 |
| HDL-C, mg/dL | 61 ± 16 | 60 ± 15 | 62 ± 16 | 0.20 |
| LDL-C, mg/dL | 107 ± 29 | 109 ± 27 | 106 ± 31 | 0.35 |
| Creatinine, mg/dL | 0.90 ± 0.59 | 0.83 ± 0.20 | 0.96 ± 0.79 | 0.02 |
| Glucose, mg/dL | 107 ± 23 | 107 ± 21 | 107 ± 25 | 0.91 |
| Hemoglobin A1c, % | 5.8 ± 0.8 | 5.8 ± 0.7 | 5.8 ± 1.0 | 0.68 |
| Hypertension | 396 (88.8) | 193 (89.8) | 203 (87.9) | 0.53 |
| Dyslipidemia | 295 (66.1) | 144 (67.0) | 151 (65.4) | 0.72 |
| Diabetes mellitus | 101 (22.6) | 50 (23.3) | 51 (22.1) | 0.77 |
| CVD | 73 (16.4) | 48 (22.3) | 25 (10.8) | 0.001 |
| Current smoker | 50 (11.2) | 26 (12.1) | 24 (10.4) | 0.57 |
| Antihypertensive drugs | 378 (95.0) | 177 (92.7) | 201 (97.1) | 0.04 |
| Lipid lowering drugs | 197 (66.1) | 98 (68.1) | 99 (64.3) | 0.49 |
| Anti-diabetic drugs | 62 (13.9) | 32 (14.9) | 30 (13.0) | 0.56 |
HDL-C indicates high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; CVD, cardiovascular disease.
Figure 1Bar graphs show flow-mediated vasodilation in subjects with sitting time on a non-working day of < 6 h/day and subjects with sitting time on a non-working day of ≥ 6 h/day.
Figure 2Scatter plots show the relationships of flow-mediated vasodilation with sitting time on a non-working day (A), total sitting time (B), sitting time on a working day (C), and occupational sitting time (D).
Multivariate analysis of relationships of low tertiles with FMD and sitting time on a non-working day.
| Sitting time | Odds ratio (95% Confidence interval); | |||
|---|---|---|---|---|
| Unadjusted | Model 1 | Model 2 | Model 3 | |
| <6 h/day | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
| ≥6 h/day | 2.37 (1.57–3.58); < 0.001 | 2.29 (1.49–3.52); < 0.001 | 2.24 (1.45–3.46); < 0.001 | 2.12 (1.37–3.29); < 0.001 |
Model 1; adjusted for age, gender, body mass index, hypertension, dyslipidemia, diabetes mellitus, current smoking.
Model 2; adjusted for age, gender, body mass index, hypertension, dyslipidemia, diabetes mellitus, current smoking, past CVD.
Model 3; adjusted for age, gender, body mass index, hypertension, dyslipidemia, diabetes mellitus, current smoking, past CVD, exercise habit.
FMD indicates flow mediated vasodilation; OR, odds ratio; CI, confidence interval.
Low tertile of FMD indicates less than 1.6%.
Clinical characteristics of subjects with sitting time on a non-working day of < 8 h/day and subjects with sitting time on a non-working day of ≥ 8 h/day.
| Variables | Total (n = 446) | < 8 h/day (n = 286) | ≥ 8 h/day (n = 160) | |
|---|---|---|---|---|
| Age, year | 66 ± 12 | 64 ± 13 | 67 ± 11 | 0.02 |
| Men, n (%) | 265 (59.4) | 181 (63.3) | 84 (52.5) | 0.03 |
| Body mass index, kg/m2 | 24.2 ± 3.7 | 23.9 ± 3.8 | 24.7 ± 3.4 | 0.03 |
| Heart rate, bpm | 68 ± 11 | 68 ± 11 | 69 ± 11 | 0.21 |
| Systolic blood pressure, mmHg | 128 ± 16 | 129 ± 16 | 126 ± 15 | 0.02 |
| Diastolic blood pressure, mmHg | 77 ± 11 | 79 ± 12 | 74 ± 10 | < 0.001 |
| Total cholesterol, mg/dL | 191 ± 35 | 191 ± 34 | 190 ± 38 | 0.72 |
| Triglycerides, mg/dL | 127 ± 68 | 124 ± 68 | 132 ± 68 | 0.27 |
| HDL-C, mg/dL | 61 ± 16 | 62 ± 15 | 60 ± 16 | 0.41 |
| LDL-C, mg/dL | 107 ± 29 | 109 ± 27 | 105 ± 32 | 0.25 |
| Creatinine, mg/dL | 0.90 ± 0.59 | 0.86 ± 0.40 | 0.97 ± 0.83 | 0.06 |
| Glucose, mg/dL | 107 ± 23 | 107 ± 22 | 107 ± 25 | 0.89 |
| Hemoglobin A1c, % | 5.8 ± 0.8 | 5.8 ± 0.8 | 5.8 ± 0.9 | 0.63 |
| Hypertension | 396 (88.8) | 243 (85.0) | 153 (95.6) | 0.001 |
| Dyslipidemia | 295 (66.1) | 188 (65.7) | 107 (66.9) | 0.81 |
| Diabetes mellitus | 101 (22.6) | 63 (22.0) | 38 (23.8) | 0.68 |
| CVD | 73 (16.4) | 59 (20.6) | 14 (8.8) | 0.001 |
| Current smoker | 50 (11.2) | 42 (14.7) | 8 (5.0) | 0.002 |
| Antihypertensive drugs | 378 (95.0) | 230 (93.9) | 148 (96.7) | 0.20 |
| Lipid-lowering drugs | 197 (66.1) | 128 (68.1) | 69 (62.7) | 0.35 |
| Antidiabetic drugs | 62 (13.9) | 39 (13.6) | 23 (14.4) | 0.83 |
HDL-C indicates high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; CVD, cardiovascular disease.
Figure 3Bar graphs show nitroglycerine-induced vasodilation in subjects with sitting time on a non-working day of < 8 h/day and subjects with sitting time on a non-working day of ≥ 8 h/day.
Figure 4Scatter plots show the relationships of nitroglycerine-induced vasodilation with sitting time on a non-working day (A), total sitting time (B), sitting time on a working day (C), and occupational sitting time (D).
Multivariate analysis of relationships of low tertiles with NID and sitting time on a non-working day.
| Sitting time | Odds ratio (95% Confidence interval); | |||
|---|---|---|---|---|
| Unadjusted | Model 1 | Model 2 | Model 3 | |
| < 8 h/day | 1 (reference) | 1 (reference) | 1 (reference) | 1 (reference) |
| ≥ 8 h/day | 2.08 (1.37–3.17); < 0.001 | 1.82 (1.16–2.87); 0.01 | 1.96 (1.23–3.13); 0.005 | 1.76 (1.10–2.84); 0.02 |
Model 1; adjusted for age, gender, body mass index, hypertension, dyslipidemia, diabetes mellitus, current smoking.
Model 2; adjusted for age, gender, body mass index, hypertension, dyslipidemia, diabetes mellitus, current smoking, past CVD.
Model 3; adjusted for age, gender, body mass index, hypertension, dyslipidemia, diabetes mellitus, current smoking, past CVD, exercise habit.
NID indicates nitroglycerine-induced vasodilation; OR, odds ratio; CI, confidence interval.
Low tertile of NID indicates less than 8.5%.